FDA Inspection
Merz Pharma GmbH & Co., KGaAMerz Pharma GmbH & Co., KGaA – FDA Inspection, Jul 4, 2017
Record Details
This FDA Inspection record concerns Merz Pharma GmbH & Co., KGaA, with an inspection on July 4, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c753b773-c4fd-403c-8c66-d824651e0b65
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1021141
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Merz Pharma GmbH & Co., KGaA
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 29, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2019 | Not classified | Office of Inspections and Investigations | |
| September 15, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merz Pharma GmbH & Co., KGaA
- FDA Inspection 1250812 - 2022-06-29
- FDA Inspection 1088213 - 2019-03-14
- FDA Inspection 945417 - 2015-09-15
- FDA Inspection 853048 - 2013-09-25
- FDA Inspection 773481 - 2011-10-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.